Yahoo! Finance: Top Stories

BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT

Jun 26, 2025 - 08:30
 0
BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT
Read More

Tags:

Previous Article

Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target

Next Article

Maxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price Target

Related Posts

Best Buy Strengthens Product Offering with UGREEN Deal

Best Buy Strengthens Product Offering with UGREEN Deal

May 27, 2025  0

Nvidia CEO Huang Spoke About AI and the U.K. Today. What It Means for the Stock.

Nvidia CEO Huang Spoke About AI and the U.K. Today. Wha...

Jun 9, 2025  0

Flywire Corporation (FLYW) Traded Lower as Guidance Fell Short of Expectations

Flywire Corporation (FLYW) Traded Lower as Guidance Fel...

May 27, 2025  0